Clinical Trial Search

Primary: Proportion of Women With Plasma HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery — .84; .94 Proportion — p=0.001

Primary: Average Over Time of Intensity of Cannabis Use (Used to Evaluate Treatment Efficacy) — 10.21; 10.2 joints smoked during the prior week — p=.99

Primary: Dose-normalized Trough — 0.59; 0.44 ng/dL

Primary: Change From Baseline in Daily Average Number of Urinary Incontinence Episodes — -2.99; -0.42 incontinence episodes per day — p=<.0001

Primary: Number of Patients With Hyperglycemia in the Intensive Care Unit (ICU) — 76; 68 Participants

Primary: Time to Recovery (TTR) of Participant Train Of Four (TOF) Ratio to ≥0.9: Primary Kaplan-Meier Analysis — 1.7; 1.8; 1.8; 3.4 Minutes — p=0.0075

Primary: Part 1: Change From Baseline in Pain Intensity at Hour 6 Using the Thermal Suprathreshold Pain in the Ultraviolet-B (UVB) Burn Pain Model — 0.73; -0.64; -0.36; 0.36…

Primary: Prothrombin Fragments f1+2 — 31.1; 34.08; 27.41; 36.02 fold-change*h — p=0.408

Primary: Change in Patient-perceived Pain Between Baseline and Cannulization — 29.5; 35 score on a scale

Primary: Sydney Resection Quotient (SRQ) — 9.3; 8.1; 12.3; 11.1 Ratio

Primary: Change From Baseline in COWA Unique Word Count — -0.407725385; -0.425898667; -0.412534118; -0.108298333 Word Count

Primary: SAEs and Severe AEs — 0; 0 Participants — p=0.05

Primary: Changes in Endothelial Function (FMD - Flow Mediated Dilatation) From Baseline to 12 Weeks — 0.4; -0.5 percentage of change in diameter (%)

Primary: Changes in 24 Hour Blood Pressure

Primary: Number of Patient Who Gained Remission From the Nephrotic Syndrome — 8; 8 Participants — p=0.7